Status:
UNKNOWN
Analysis of the Cost-Effectiveness of Same-day Discharge Surgery for Primary Total Hip Arthroplasty
Lead Sponsor:
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Conditions:
Hip Arthropathy
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Total hip arthroplasty (THA) causes a great medical burden globally, and the same-day discharge (SDD) method has previously been considered to be cost saving. However, a standard cost-effectiveness an...
Detailed Description
This was a prospective RCT. Patients qualified for inclusion in the study if they met the following criteria: undergoing unilateral primary THA; having the ability to understand the relevant treatment...
Eligibility Criteria
Inclusion
- undergoing unilateral primary THA
- having the ability to understand the relevant treatment process
- aged between 18 and 75 years
- a body mass index (BMI) ≤ 40 kg/m2
- hemoglobin ≥ 12g/dL
- American Society of Anesthesiologists (ASA) physical status classification of I or II
- no ongoing infection or blood coagulation disorders
Exclusion
- with a history of coronary artery disease
- chronic obstructive pulmonary disease
- arrhythmias
- untreated obstructive sleep apnea
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 15 2021
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT04900181
Start Date
July 1 2020
End Date
July 15 2021
Last Update
May 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wuhan Union Hospital
Wuhan, Hubei, China, 430000